The ESCMID Emerging Infections Subcommittee has published their intensive commentary on the recent mpox outbreak providing evidence-based information for healthcare professionals, researchers, and public health officials.

As of August 2024, the mpox outbreak has primarily affected countries in Central and East Africa, particularly the Democratic Republic of the Congo (DRC) and neighbouring countries, with cases reported across several regions.

Read the full report on the ESCMID website.

Science & Research

This is the last chance to submit your application or nominate your outstanding colleagues for an ESCMID Award. These awards celebrate excellence and innovation in the field of infection and there are awards for members at all stages of their career. See what awards are available and apply online before 2 September 2024.

Four members of the current ESCMID SAS are completing their term at the end of ESCMID Global 2025. ESCMID is now searching for members to replace them in April. The open call covers the following topics: AMR & Susceptibility Testing, Clinics & Therapeutics, Pathogenesis and Immunology and finally, Diagnostics. Interested members can review the full call sheet and apply by 30 September 2024.

Education

The programme offers cutting-edge insights into infection prevention, innovative diagnostics, and emerging antimicrobial therapies. Through engaging lectures, real-world case studies, and interactive discussions, you'll gain practical skills to optimise patient care in this critical field.

This onsite event is designed for researchers in clinical microbiology and infectious diseases, focusing on crafting clear research questions, selecting appropriate study designs, avoiding biases, and writing effective reports. Led by Marc Bonten and organised by ESGIE, ESGBIES, Ecraid, and CMI, this workshop promises to enhance your research skills using cutting-edge methods and participant projects as examples.

Register by 22 September 2024, to secure your spot.

Congress & Events

Block your calendars for the 2024 ESCMID/ASM joint conference on drug development in Porto, Portugal from 17–20 September 2024. Co-hosted by ESCMID and ASM, this interdisciplinary summit pledges to tackle the growing threat of AMR, and explore opportunities and outline essential criteria for advancing antimicrobial drug development.

There are still seats available, so be sure to register either onsite or online to take part in this event that covers academia, industry and political themes surrounding drug development and AMR.

Guidelines & Journals

In this episode of Communicable, “The Nightmare Series, part 1: How to deal with Candida auris” hosts Emily McDonald and Navaneeth Narayanan are joined by fungal experts Dr. Jeffrey Rybak (St. Jude, Memphis TN) and Dr. Graham Snyder (UPMC, Pittsburgh PA) on their quest to better understand C. auris infections, the clinical challenges and knowledge gaps in C. auris research and discuss measures for prevention and containment on the levels of both the patient and the institution.

ESCMID/EUCIC clinical guidelines on preoperative decolonization and targeted prophylaxis in patients colonized by multidrug-resistant Gram-positive bacteria before surgery

Antibiotics’ collateral effects on the gut microbiota in the selection of ESKAPE pathogens

ESCMID Certificate Programmes have specific modules open for general participation. You can now join selected courses without enrolling for the full programmes

AMS Certificate Programme / EUCIC Certificate Programme